Monday, 29 July 2013
Salam Ramadhan ke 20
Sunday, 28 July 2013
Ubat tahan sakit: acugesic
| Manufacturer | CCM Duopharma BioTech |
| Distributor | CCM Duopharma BioTech |
| Contents | Tramadol HCl |
| Indications | Severe acute & chronic pain. Painful diagnostic or therapeutic measures. |
| Dosage | Oral Adult & adolescent >14 yr 1 cap/tab. Inj Adult & adolescent >14 yr 50-100 mg IV, IM, SC. Childn from 1 yr 1-2 mg/kg body wt. Max: 400 mg. |
| Administration | May be taken with or without food. |
| Contraindications | Acute intoxication w/ alcohol, hypnotics, analgesics, opioids or psychotropic drugs. |
| Special Precautions | Myasthenia gravis, renal & hepatic impairment, head injury, increased intracranial pressure, shock, resp disorders, impaired consciousness, w/drawal syndrome. Childn <12 yr. Pregnancy & lactation. May impair ability to drive or operate machinery. |
| Adverse Drug Reactions | Sweating, dizziness, nausea, vomiting, dry mouth, fatigue. View ADR Monitoring Website |
| Drug Interactions | CNS depressants, MAOI, carbamazepine. |
Antibiotik ku....
Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.[1] It was approved by FDA on Dec 28, 1987.[2] It is available by GSK as Ceftin in US[3] and Ceftum in India.[4]
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets and other antibacterial drugs, cefuroxime axetil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
DESCRIPTION
Cefuroxime axetil tablets contain cefuroxime as cefuroxime axetil. Cefuroxime axetil tablets is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration.
Chemically, cefuroxime axetil, the 1-(acetyloxy) ethyl ester of cefuroxime, is (RS)-1-hydroxyethyl (6R,7R)-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1- azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-(Z)-(O-methyloxime), 1-acetate 3-carbamate. Its molecular formula is C20H22N4O10S, and it has a molecular weight of 510.48.
Cefuroxime axetil is in the amorphous form and has the following structural formula:

Cefuroxime axetil tablets are uncoated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil. Cefuroxime axetil tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, hydrogenated vegetable oil, microcrystalline cellulose and sodium lauryl sulfate.
Friday, 26 July 2013
Klinik Anestetik
- To provide anesthetics, intensive care and related services of high quality and consistent with established high standards of care.
- To increase awareness among patients and other caregivers about anaesthesia and the role anaesthetists play in their treatment and eventual recovery.
- To actively carry out Continuing Professional Development (CPD) for the staff of the department inclusive of doctors, nurse and paramedics as we believe that CPD activities will eventually translate into high standards of patient care.
- To promote good teamwork and excellent working relationships among all members of the department.
- To carry out continuous quality improvement activities so that it becomes a tool for improving the standard of services and is institutionalized in the department.
- To carry out clinical research which may include the use of new drugs that are about to be registered in the country.









